Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1975 Sep;72(9):3683–3686. doi: 10.1073/pnas.72.9.3683

Competitive protein binding assay for methotrexate.

C E Myers, M E Lippman, H M Elliot, B A Chabner
PMCID: PMC433061  PMID: 810804

Abstract

A competitive protein binding assay has been developed for methotrexate based on the tight binding of this drug to Lactobacillus casei dihydrofolate reductase (= tetrahydrofolate dehydrogenase; 5,6,7,8-tetrahydrofolate: NADP+ oxidoreductase; EC 1.5.1.3). Free drug may be separated from that bound to reductase by adsorption with dextran--albumin coated charcoal. Scatchard plot analysis of the enzyme--drug interaction confirmed the presence of a single homogeneous class of binding sites with an association constant Ka of 2.1 X 10(8) M-1. This high affinity binding permits detection of methotrexate in the range of 0.3--30 pmol with a coefficient of variation of 15% or less. The predominant circulating folate, 5-methyl tetrahydrofolate, and the clinically useful rescue agent leucovorin (5-formyl tetrahydropteroyl-glutamic acid) do not interfere with the assay, nor does the methotrexate metabolite 4-amino-4-deoxy-10-methylpteroic acid. Assay of clinical samples, including plasma and cerebrospinal fluid, showed close agreement between the previously described enzyme inhibition assay and the more rapid competitive binding method.

Full text

PDF
3683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTINO J. R., BOOTH B. A., BIEBER A. L., CASHMORE A., SARTORELLI A. C. STUDIES ON THE INHIBITION OF DIHYDROFOLATE REDUCTASE BY THE FOLATE ANTAGONISTS. J Biol Chem. 1964 Feb;239:479–485. [PubMed] [Google Scholar]
  2. BERTINO J. R., FISCHER G. A. TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS. Methods Med Res. 1964;10:297–307. [PubMed] [Google Scholar]
  3. Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. J Pharm Sci. 1971 Aug;60(8):1128–1133. doi: 10.1002/jps.2600600803. [DOI] [PubMed] [Google Scholar]
  4. Bischoff K. B., Dedrick R. L., Zaharko D. S. Preliminary model for methotrexate pharmacokinetics. J Pharm Sci. 1970 Feb;59(2):149–154. doi: 10.1002/jps.2600590203. [DOI] [PubMed] [Google Scholar]
  5. Bleyer W. A., Drake J. C., Chabner B. A. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med. 1973 Oct 11;289(15):770–773. doi: 10.1056/NEJM197310112891503. [DOI] [PubMed] [Google Scholar]
  6. Burchall J. J. Comparative biochemistry of dihydrofolate reductase. Ann N Y Acad Sci. 1971 Nov 30;186:143–152. doi: 10.1111/j.1749-6632.1971.tb46965.x. [DOI] [PubMed] [Google Scholar]
  7. Chabner B. A., Young R. C. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. J Clin Invest. 1973 Aug;52(8):1804–1811. doi: 10.1172/JCI107362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frei E., 3rd, Jaffe N. J., Pitman S. Letter: Limitations of methotrexate and citrovorum-factor treatments. N Engl J Med. 1975 Jan 9;292(2):107–108. doi: 10.1056/NEJM197501092920216. [DOI] [PubMed] [Google Scholar]
  9. JOHNS D. G., BERTINO J. R. FOLATES AND MEGALOBLASTIC ANEMIA: A REVIEW. Clin Pharmacol Ther. 1965 May-Jun;6:372–392. doi: 10.1002/cpt196563372. [DOI] [PubMed] [Google Scholar]
  10. Jaffe N., Frei E., 3rd, Traggis D., Bishop Y. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med. 1974 Nov 7;291(19):994–997. doi: 10.1056/NEJM197411072911902. [DOI] [PubMed] [Google Scholar]
  11. Kay H. E., Knapton P. J., O'Sullivan J. P., Wells D. G., Harris R. F., Innes E. M., Stuart J., Schwartz F. C., Thompson E. N. Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child. 1972 Jun;47(253):344–354. doi: 10.1136/adc.47.253.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Levine L., Powers E. Radioimmunoassay for methotrexate. Res Commun Chem Pathol Pharmacol. 1974 Nov;9(3):543–554. [PubMed] [Google Scholar]
  13. Otting F., Huennekens F. M. TPNH-dependent binding of amethopterin by dihydrofolate reductase from Lactobacillus casei. Arch Biochem Biophys. 1972 Sep;152(1):429–431. doi: 10.1016/0003-9861(72)90234-2. [DOI] [PubMed] [Google Scholar]
  14. Pinkel D., Hernandez K., Borella L., Holton C., Aur R., Samoy G., Pratt C. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer. 1971 Feb;27(2):247–256. doi: 10.1002/1097-0142(197102)27:2<247::aid-cncr2820270202>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  15. Rodbard D., Bridson W., Rayford P. L. Rapid calculation of radioimmunoassay results. J Lab Clin Med. 1969 Nov;74(5):770–781. [PubMed] [Google Scholar]
  16. Valerino D. M., Johns D. G., Zaharko D. S., Oliverio V. T. Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid. Biochem Pharmacol. 1972 Mar 15;21(6):821–831. doi: 10.1016/0006-2952(72)90125-6. [DOI] [PubMed] [Google Scholar]
  17. WERKHEISER W. C., ZAKRZEWSKI S. F., NICHOL C. A. Assay for 4-amino folic acid analogues by inhibition of folic acid reductase. J Pharmacol Exp Ther. 1962 Aug;137:162–166. [PubMed] [Google Scholar]
  18. Wan S. H., Huffman D. H., Azarnoff D. L., Stephens R., Hoogstraten B. Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res. 1974 Dec;34(12):3487–3491. [PubMed] [Google Scholar]
  19. Waxman S., Schreiber C. Measurement of serum folate levels and serum folic acid-binding protein by 3H-PGA radioassay. Blood. 1973 Aug;42(2):281–290. [PubMed] [Google Scholar]
  20. Zaharko D. S., Bruckner H., Oliverio V. T. Antibiotics alter methotrexate metabolism and excretion. Science. 1969 Nov 14;166(3907):887–888. doi: 10.1126/science.166.3907.887. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES